英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
N-methylnitrous hydrazide |
N-甲基-N-亞硝基-2-丙胺 |
30533-08-5 |
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)C |
|
詳細(xì)
|
NA |
莫匹羅星4 |
|
詳細(xì)
|
2,3,5-Trichlorobenzoic acid |
伊沙佐米雜質(zhì)12 |
50-73-7 |
詳細(xì)
|
Imrecoxib |
艾瑞昔布 |
395683-14-4 |
詳細(xì)
|
CHEMBRDG-BB 7959525 |
伊沙佐米雜質(zhì)10 |
667403-46-5 |
詳細(xì)
|
Ixazomib Impurity 7 |
伊沙佐米雜質(zhì)7 |
|
詳細(xì)
|
2,3,4-TRICHLOROBENZOIC ACID |
伊沙佐米雜質(zhì)11 |
50-75-9 |
詳細(xì)
|
2-Naphthacenecarboxamide, 7-(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,4,11-trioxo-, (4aR,5aR,12aS)- |
奧瑪環(huán)素雜質(zhì)M-2雜質(zhì) |
885112-31-2 |
詳細(xì)
|
Benzamide, 2,5-dichloro-N-[2-[(3-methylbutyl)amino]-2-oxoethyl]- |
伊沙佐米雜質(zhì)24 |
2872629-73-5 |
詳細(xì)
|
PseudoMonic Acid F |
莫匹羅星EP雜質(zhì)F |
167842-64-0 |
詳細(xì)
|
Pseudomonic Acid D |
莫匹羅星EP雜質(zhì)C |
85248-93-7 |
詳細(xì)
|
Potassium Clavulanate EP lmpurity M |
克拉維酸鉀 EP 雜質(zhì)M |
103526-47-2 |
詳細(xì)
|
N-nitroso-varenicline |
|
|
詳細(xì)
|
N-nitroso-vancomycin |
|
|
詳細(xì)
|
NA |
4-((E)-((1SR,4SR)-7,7-二甲基-3-氧代-4-(磺甲基)二環(huán)[2.2.1]庚-2-亞基)甲基)苯甲酸 |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)D |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)I |
|
詳細(xì)
|
(3S,5R)-3-(Boc-aMino)-5-Methylpiperidine |
N-[(3S,5R)-5-甲基-3-哌啶基]氨基 甲酸叔丁酯 |
1203651-07-3 |
詳細(xì)
|
Ixazomib Impurity 3 |
伊沙佐米雜質(zhì)3 |
|
詳細(xì)
|
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4R,4aS,5aR,12aS)- |
4-Beta異構(gòu)體 |
601455-29-2 |
詳細(xì)
|
2-Naphthacenecarboxamide, 9-[[(aminocarbonyl)(2,2-dimethylpropyl)amino]methyl]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- |
奧瑪環(huán)素雜質(zhì)4 |
2272886-37-8 |
詳細(xì)
|
N-nitroso-vilanterol |
|
|
詳細(xì)
|
Edaravone Impurity 35 |
依達(dá)拉奉雜質(zhì) 35 |
|
詳細(xì)
|
NA |
伊沙佐米雜質(zhì)23 |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)A |
|
詳細(xì)
|
NA |
奈諾沙星中間體2雜質(zhì)2 |
|
詳細(xì)
|
Omadacycline |
奧瑪環(huán)素 |
389139-89-3 |
詳細(xì)
|
Ixazomib citrate (USAN) |
伊沙佐米雜質(zhì)19 |
1239908-20-3 |
詳細(xì)
|
Ixazomib Impurity 8 |
伊沙佐米雜質(zhì)8 |
1378314-08-9 |
詳細(xì)
|
Imrecoxib Impurity 9 |
959003-56-6 |
959003-56-6 |
詳細(xì)
|
Imrecoxib Impurity 5 |
艾瑞昔布雜質(zhì) |
2305368-53-8 |
詳細(xì)
|
NA |
((1SR,4SR.E)-3-(4-(羥甲基)亞芐基)-7,7-二甲基-2-氧代雙環(huán)[2.2.1]
庚-1-基)甲磺酸鈉 |
|
詳細(xì)
|
5-(acetoxymethyl)-2-(amino(carboxy)methyl)-3-nitroso-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
5-(乙酰氧基甲基)-2-(氨基(羧基)甲基)-3-亞硝基-3,6-二氫-2H-1,3-噻嗪-4-羧酸 |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)H |
|
詳細(xì)
|
NA |
奈諾沙星原料雜質(zhì)1 |
|
詳細(xì)
|
(R,E)-2-methyl-N-(3-methylbutylidene)propane-2-sulfinamide |
伊沙佐米雜質(zhì)21 |
220315-20-8 |
詳細(xì)
|
Ixazomib Impurity 5 |
伊沙佐米雜質(zhì)5 |
|
詳細(xì)
|
Mupirocin EP Impurity D |
莫匹羅星EP雜質(zhì)D |
71087-97-3 |
詳細(xì)
|
Urea, N-[2-(dimethylamino)ethyl]-N'-ethyl- |
伊沙佐米雜質(zhì)4 |
62594-29-0 |
詳細(xì)
|
Imrecoxib Impurity 7 |
艾瑞昔布雜質(zhì)7 |
|
詳細(xì)
|
NA |
4-((E)-((1SR,4SR)-7,7-二甲基-3-氧代-4-(磺甲基)二環(huán)[2.2.1]庚-2-亞基)甲基)苯甲醛鈉鹽 |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)E |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)J |
|
詳細(xì)
|
Pseudomonic acid C |
莫匹羅星EP雜質(zhì)B |
1980-98-8 |
詳細(xì)
|
PseudoMonic Acid D SodiuM |
莫匹羅星EP雜質(zhì)C鈉鹽 |
85178-60-5 |
詳細(xì)
|
Benzamide, 2,5-dichloro-N-(3-methylbutyl)- |
伊沙佐米雜質(zhì)17 |
349086-08-4 |
詳細(xì)
|
Ixazomib Impurity 20 |
伊沙佐米雜質(zhì)20 |
|
詳細(xì)
|
NA |
伊沙佐米雜質(zhì)25 |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)B |
|
詳細(xì)
|
NA |
奈諾沙星中間體2雜質(zhì)3 |
|
詳細(xì)
|
3H-Pyrazol-3-one, 2,4-dihydro-4,4-bis(5-hydroxy-3-Methyl- 1-phenyl-1H-pyrazol-4-yl)-5-Methyl-2-phenyl- |
依達(dá)拉奉雜質(zhì)6 |
124009-63-8 |
詳細(xì)
|
tert-butyl N-[(3R,5S)-5-methylpiperidin-3-yl]carbamate |
N-[(3R,5S)-5-甲基-3-哌啶基]氨基 甲酸叔丁酯 |
1270019-92-5 |
詳細(xì)
|
Benzamide, 2,5-dichloro-N-[2-[(3-methylbutylidene)amino]-2-oxoethyl]- |
伊沙佐米雜質(zhì)18 |
1429055-05-9 |
詳細(xì)
|
MethylltrexoneHoffmanElimitionImpurity |
溴甲納曲酮雜質(zhì)3 |
1005410-47-8 |
詳細(xì)
|
(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[(2,2-dimethylpropyl)methylamino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide |
奧瑪環(huán)素雜質(zhì)2 |
488819-64-3 |
詳細(xì)
|
Butanedioicacid,2-hydroxy-,compd.with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylicacid |
蘋果酸奈諾沙星 |
951163-60-3 |
詳細(xì)
|
MLN9708 |
伊沙佐米雜質(zhì)9 |
1201902-80-8 |
詳細(xì)
|
5-(2-Bromo-1-oxobutyl)-8-hydroxy-2(1H)-quinolinone |
丙卡特羅雜質(zhì)1 |
59827-93-9 |
詳細(xì)
|
(3R,5R)-3-(Boc-amino)-5- Methylpiperidine |
(3R,5R)-3-(BOC-氨基)-5-甲基哌啶 |
1227919-32-5 |
詳細(xì)
|
Ixazomib Impurity 6 |
伊沙佐米雜質(zhì)6 |
|
詳細(xì)
|
Mupirocin EP Impurity E |
莫匹羅星EP雜質(zhì)E |
71087-96-2 |
詳細(xì)
|
Imrecoxib Impurity 6 |
1338083-52-5 |
1338083-52-5 |
詳細(xì)
|
2,4,5-Trichlorobenzoic acid |
伊沙佐米雜質(zhì)13 |
50-82-8 |
詳細(xì)
|
8-Hydroxyquinoline-N-oxide |
8-羥基喹啉 N-氧化物 |
1127-45-3 |
詳細(xì)
|
monic acid A |
莫匹羅星單胞菌酸A |
66262-68-8 |
詳細(xì)
|
24,25-Dihydroxyfusidic Acid |
夫西地酸鈉EP雜質(zhì)A |
80445-74-5 |
詳細(xì)
|
Imrecoxib Impurity 1 |
Imrecoxib |
896729-07-0 |
詳細(xì)
|
NA |
奈諾沙星中間體1雜質(zhì)1 |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)F |
|
詳細(xì)
|
NA |
丙卡特羅原料硝化雜質(zhì) |
|
詳細(xì)
|
(1R,2S)-1-(3-(allyloxy)phenyl)-1-hydroxypropan-2-aminium chloride |
(1R,2S)-1-(3-(烯丙氧基)苯)-1-羥基丙烷-2-氯化銨 |
|
詳細(xì)
|
Mupirocin EP Impurity I |
莫匹羅星EP雜質(zhì)I |
|
詳細(xì)
|
N-nitroso-desmethyl-zolmitriptan |
|
|
詳細(xì)
|
Edaravone Impurity 2 |
依達(dá)拉奉雜質(zhì) 32 |
852539-02-7 |
詳細(xì)
|
NA |
伊沙佐米雜質(zhì)26 |
|
詳細(xì)
|
NA |
莫匹羅星5 |
|
詳細(xì)
|
NA |
奈諾沙星原料雜質(zhì)2 |
|
詳細(xì)
|
NA |
奈諾沙星對映異構(gòu)體 |
|
詳細(xì)
|
sodium (R)-2-((R)-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)(carboxylato)methyl)-5-(((2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl)-3-nitroso-3,6-dihydro-2H-1,3-thiazine-4-carboxylate |
鈉(R)-2-((R)-((E)-2-(2-氨基噻唑-4-基)-2-(甲氧基亞氨基)乙酰氨基)(羧基化)甲基)-5-(((2-甲基-6-氧化-5-氧代-2,5-二氫-1,2,4-三嗪-3-基)硫代)甲基)-3-亞硝基-3,6-二氫-2H-1,3-噻嗪-4-羧酸酯 |
|
詳細(xì)
|
N-nitroso-viloxazine |
N-亞硝基維洛沙秦 |
|
詳細(xì)
|
Amlodipine Impurity 82 |
氨氯地平雜質(zhì)82 |
|
詳細(xì)
|
Imrecoxib Impurity 92 |
艾瑞昔布雜質(zhì)92 |
|
詳細(xì)
|
Edaravone Impurity 36 |
依達(dá)拉奉雜質(zhì) 36 |
|
詳細(xì)
|
N-nitroso-vortioxetine |
N-亞硝基伏替西汀 |
|
詳細(xì)
|
(3S,4R,4aS,7aR)-3-(cyclopropylmethyl)-4a-hydroxy-9-methoxy-3-methyl-7-oxo-2,3,4,4a,5, 6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium bromide |
溴甲納曲酮雜質(zhì)1 |
1005410-37-6 |
詳細(xì)
|
NA |
奈諾沙星中間體1雜質(zhì)2 |
|
詳細(xì)
|
NA |
奈諾沙星雜質(zhì)G |
|
詳細(xì)
|
2-(amino(carboxy)methyl)-5-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl)-3-nitroso-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
2-(氨基(羧基)甲基)-5-(((6-羥基-2-甲基-5-氧代-2,5-二氫-1,2,4-三嗪-3-基)硫代)甲基)-3-亞硝基-3,6-二氫-2H-1,3-噻嗪-4-羧酸 |
|
詳細(xì)
|
NA |
((1SR,4RS)-7,7-二甲基-2-氧代雙環(huán)[2.2.1]庚-1-基)甲磺酸 |
|
詳細(xì)
|
2,5-dichloro-N,N-dimethylbenzamide |
伊沙佐米雜質(zhì)15 |
90526-01-5 |
詳細(xì)
|
Nemonoxacin Impurity 1 |
奈諾沙星差向異構(gòu)體2 |
378746-65-7 |
詳細(xì)
|
Boronic acid, B-[(1R)-1-[(2,5-dichlorobenzoyl)amino]-3-methylbutyl]- |
伊沙佐米雜質(zhì)16 |
2806031-79-6 |
詳細(xì)
|
Imrecoxib Impurity 4 |
2'-羥基-4-甲砜基苯乙酮 |
197240-27-0 |
詳細(xì)
|
NA |
夫西地酸鈉EP雜質(zhì)B |
|
詳細(xì)
|
NA |
奈諾沙星中間體2雜質(zhì)1 |
|
詳細(xì)
|
NA |
奈諾沙星差向異構(gòu)體1 |
|
詳細(xì)
|
NA |
伊沙佐米雜質(zhì)22 |
|
詳細(xì)
|
N-nitroso-vibegron |
|
|
詳細(xì)
|
N-nitroso-desmethyl-venlafaxine |
|
|
詳細(xì)
|